Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Japan Medical Dynamic Marketing, Inc. ( (JP:7600) ).
Japan Medical Dynamic Marketing reported a 2.9% year-on-year decline in net sales to ¥17.9 billion for the nine months ended December 31, 2025, with operating profit dropping 57.9% to ¥518 million and profit attributable to owners of parent falling 67.3% to ¥287 million, reflecting a significant contraction in earnings despite relatively stable assets and a high equity ratio of 72.9%. While the balance sheet remained solid and equity increased slightly, the company expects continued profit pressure for the full year to March 31, 2026, forecasting a further sharp decline in operating and ordinary profit, even as it plans to raise its annual dividend from ¥15 to ¥17 per share, signaling management’s intent to maintain shareholder returns despite weaker profitability.
The most recent analyst rating on (JP:7600) stock is a Hold with a Yen527.00 price target. To see the full list of analyst forecasts on Japan Medical Dynamic Marketing, Inc. stock, see the JP:7600 Stock Forecast page.
More about Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, Inc. is a Japan-based medical company listed on the Tokyo Stock Exchange that operates under Japanese GAAP. It focuses on marketing and supplying medical-related products, particularly to the domestic healthcare market, generating consolidated net sales of around ¥25 billion on an annual basis.
Average Trading Volume: 86,003
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen12.85B
Learn more about 7600 stock on TipRanks’ Stock Analysis page.